Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jee Hye Kang

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Trends in Cancer|August 19, 2023
Modulating Treg stability to improve cancer immunotherapyJee Hye Kang, Roberta Zappasodi
Trends in Immunology|March 14, 2021
Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting CytokinesJee Hye Kang, Jeffrey A Bluestone, Arabella Young
Molecular and Cellular Probes|August 10, 2024
New potential diagnostic markers for verrucous hyperplasia and verrucous carcinoma based on RNA-sequencing dataJanghyun Kim, Jee-Hye Kang, Myung-Giun Noh, et al.
Circulation. Cardiovascular Imaging|October 8, 2009
Apical rotation assessed by speckle-tracking echocardiography as an index of global left ventricular contractilityWon-Jang Kim, Byeong Han Lee, Yun Jeong Kim, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responsesInna Serganova, Giorgia Colombo, Francesco Ballesio, et al.
Journal of the Endocrine Society|March 2, 2023
Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced HypophysitisZoe Quandt, Stephanie Kim, Javier Villanueva-Meyer, et al.
BJC Reports|November 8, 2024
Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of responseZoe Quandt, Saya Jacob, Muhammad Zaki Hidayatullah Fadlullah, et al.
Journal for Immunotherapy of Cancer|August 14, 2025
Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreasZoe Quandt, Arabella Young, Graham Larson Barlow, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Trends in Cancer|August 19, 2023
Modulating Treg stability to improve cancer immunotherapyJee Hye Kang, Roberta Zappasodi
Trends in Immunology|March 14, 2021
Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting CytokinesJee Hye Kang, Jeffrey A Bluestone, Arabella Young
Molecular and Cellular Probes|August 10, 2024
New potential diagnostic markers for verrucous hyperplasia and verrucous carcinoma based on RNA-sequencing dataJanghyun Kim, Jee-Hye Kang, Myung-Giun Noh, et al.
Circulation. Cardiovascular Imaging|October 8, 2009
Apical rotation assessed by speckle-tracking echocardiography as an index of global left ventricular contractilityWon-Jang Kim, Byeong Han Lee, Yun Jeong Kim, et al.
Biorxiv : the Preprint Server for Biology|May 13, 2026
A tumor metabolism-angiogenesis-immune axis governs immunotherapy responsesInna Serganova, Giorgia Colombo, Francesco Ballesio, et al.
Journal of the Endocrine Society|March 2, 2023
Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced HypophysitisZoe Quandt, Stephanie Kim, Javier Villanueva-Meyer, et al.
BJC Reports|November 8, 2024
Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of responseZoe Quandt, Saya Jacob, Muhammad Zaki Hidayatullah Fadlullah, et al.
Journal for Immunotherapy of Cancer|August 14, 2025
Autoimmune origin for immune checkpoint inhibitor-diabetes revealed by deep immune phenotyping of the pancreasZoe Quandt, Arabella Young, Graham Larson Barlow, et al.
Pageof 1